Based on technical review and expert consensus, a guideline committee put together by the American Gastroenterological Association (AGA) released official recommendations on the laboratory evaluation of functional diarrhea and diarrhea-predominant irritable bowel syndrome (IBS-D) in immunocompetent adults. This report was published in Gastroenterology. Members of the AGA guideline committee and authors of the technical review…
The American Gastroenterological Association issued a clinical practice update outlining dietary best practices for patients with irritable bowel syndrome.
Patients living with IBS require a full understanding of what triggers and affects their gut in a negative way. What role do stress and anxiety play in IBS development and symptom severity?
For patients with irritable bowel syndrome, those who are male and/or have low Alistipes levels are more likely to be nonresponders to fecal microbiota transplantation.
Researchers assessed the influence of the COVID-19 pandemic on psychological distress and GI symptoms among patients with IBS and comorbid anxiety and/or depression.
Open-label placebo may have a beneficial effect for the treatment of functional abdominal pain or irritable bowel syndrome in children and adolescents.
Investigators compared mucosal permeability in patients with IBS-D without bile acid diarrhea (BAD) and in those with BAD, as well as with normal healthy volunteers.
Given the overall prevalence of irritable bowel syndrome, it is important for clinicians to be able to distinguish postinfectious irritable bowel syndrome from its other subtypes.
Researchers conducted a meta-analysis to assess the efficacy of a low FODMAP diet in patients with IBS and compared this efficacy with other dietary interventions.
Given the close relationship between IBS and mental health, the use of psychological modalities represents a growing area of interest in IBS management.